News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
108,236 Results
Type
Article (4252)
Company Profile (18)
Press Release (103966)
Section
Business (31975)
Career Advice (108)
Deals (5249)
Drug Delivery (5)
Drug Development (5402)
Employer Resources (11)
FDA (3199)
Job Trends (2077)
News (46957)
Policy (3871)
Tag
Academia (363)
Allergies (9)
Alliances (11183)
ALS (6)
Alzheimer's disease (317)
Antibody-drug conjugate (ADC) (5)
Approvals (3211)
Artificial intelligence (91)
Autoimmune disease (1)
Automation (4)
Bankruptcy (46)
Best Places to Work (1718)
BIOSECURE Act (1)
Biosimilars (7)
Biotechnology (10)
Bladder cancer (11)
Brain cancer (6)
Breast cancer (65)
Cancer (447)
Cardiovascular disease (27)
Career advice (99)
Career pathing (1)
CAR-T (10)
Cell therapy (26)
Cervical cancer (7)
Clinical research (4192)
Collaboration (183)
Compensation (16)
COVID-19 (481)
CRISPR (1)
C-suite (39)
Cystic fibrosis (9)
Data (267)
Decentralized trials (1)
Depression (6)
Diabetes (17)
Diagnostics (5830)
Digital health (7)
Diversity (1)
Diversity, equity & inclusion (3)
Drug discovery (14)
Drug pricing (3)
Drug shortages (1)
Duchenne muscular dystrophy (5)
Earnings (10529)
Employer branding (2)
Employer resources (11)
Events (13599)
Executive appointments (114)
FDA (3403)
Fibrodysplasia Ossificans Progressiva (1)
Funding (128)
Gene editing (2)
Generative AI (8)
Gene therapy (14)
GLP-1 (40)
Government (624)
Guidances (18)
Healthcare (2909)
IgA nephropathy (1)
Immunology and inflammation (6)
Indications (2)
Infectious disease (510)
Inflammatory bowel disease (13)
Influenza (12)
Intellectual property (8)
Interviews (12)
IPO (1800)
IRA (1)
Job creations (402)
Job search strategy (94)
Kidney cancer (5)
Labor market (1)
Layoffs (24)
Leadership (1)
Legal (533)
Liver cancer (11)
Lung cancer (50)
Lymphoma (33)
Machine learning (2)
Management (3)
Manufacturing (45)
MASH (6)
Medical device (2464)
Medtech (2464)
Mergers & acquisitions (3546)
Metabolic disorders (36)
Multiple sclerosis (20)
NASH (3)
Neurodegenerative disease (11)
Neuropsychiatric disorders (1)
Neuroscience (375)
NextGen: Class of 2025 (703)
Non-profit (547)
Now hiring (2)
Obesity (13)
Opinion (11)
Ovarian cancer (15)
Pain (4)
Pancreatic cancer (10)
Parkinson's disease (15)
Partnered (3)
Patents (24)
Patient recruitment (9)
Peanut (4)
People (8995)
Pharmaceutical (1)
Phase I (1263)
Phase II (1757)
Phase III (1612)
Pipeline (157)
Policy (2)
Postmarket research (212)
Preclinical (591)
Press Release (11)
Prostate cancer (38)
Psychedelics (1)
Radiopharmaceuticals (120)
Rare diseases (29)
Real estate (865)
Recruiting (5)
Regulatory (3024)
Reports (10)
Research institute (425)
Resumes & cover letters (15)
Rett syndrome (1)
Schizophrenia (1)
Series A (16)
Series B (13)
Service/supplier (2)
Sickle cell disease (1)
Spinal muscular atrophy (10)
Sponsored (5)
Startups (623)
Stomach cancer (2)
Supply chain (6)
The Weekly (1)
Vaccines (41)
Venture capitalists (6)
Weight loss (4)
Women's health (6)
Date
Today (8)
Last 7 days (93)
Last 30 days (383)
Last 365 days (4798)
2025 (1774)
2024 (5116)
2023 (6128)
2022 (10209)
2021 (9617)
2020 (8992)
2019 (6146)
2018 (4853)
2017 (5399)
2016 (5389)
2015 (6109)
2014 (4630)
2013 (4127)
2012 (4435)
2011 (4631)
2010 (4078)
Location
Africa (131)
Alabama (6)
Alaska (1)
Arizona (59)
Arkansas (2)
Asia (5338)
Australia (1253)
California (820)
Canada (268)
China (33)
Colorado (56)
Connecticut (63)
Delaware (7)
Europe (15234)
Florida (109)
Georgia (38)
Idaho (4)
Illinois (108)
India (4)
Indiana (35)
Iowa (4)
Japan (24)
Kansas (12)
Kentucky (4)
Louisiana (1)
Maine (20)
Maryland (106)
Massachusetts (434)
Michigan (65)
Minnesota (75)
Missouri (28)
Montana (4)
Nebraska (8)
Nevada (1)
New Hampshire (18)
New Jersey (152)
New Mexico (17)
New York (307)
North Carolina (184)
North Dakota (6)
Northern California (373)
Ohio (31)
Oklahoma (2)
Oregon (7)
Pennsylvania (86)
Rhode Island (5)
South America (154)
South Carolina (4)
Southern California (301)
Tennessee (33)
Texas (189)
United States (3265)
Utah (90)
Virginia (39)
Washington D.C. (7)
Washington State (77)
Wisconsin (35)
108,236 Results for "interpace diagnostics".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Effective May 2, 2025, Interpace Diagnostics® Will No Longer Accept Specimens for PancraGEN®, a Molecular Diagnostic Test That Assesses Pancreatic Cyst Cancer Risk
April 25, 2025
·
6 min read
Press Releases
Interpace Biosciences Announces First Quarter 2025 Financial and Business Results
May 9, 2025
·
8 min read
Pharm Country
Interpace Diagnostics Announces New Data Analyzing Imbalance of Short Tandem Repeat Alleles for Pancreatic Cancer Detection Published as an ASCO 2024 Abstract
Interpace Diagnostics®, a subsidiary of Interpace Biosciences®, is proud to announce that new data demonstrating the application of advanced sequencing technologies in pancreatic cancer was published as an e-abstract as part of the 2024 American Society of Clinical Oncology Annual Meeting.
June 4, 2024
·
6 min read
Press Releases
Interpace Biosciences Announces Preliminary Full-year and Fourth Quarter 2024 Financial and Business Results
January 31, 2025
·
5 min read
Business
Interpace Biosciences Announces First Quarter 2024 Financial and Business Results
Interpace Biosciences, Inc. announced financial results for the first quarter ended March 31, 2024 and provided a business and financial update.
May 9, 2024
·
9 min read
Press Releases
PancraGEN® Will Continue to be Offered While Interpace Re-evaluates its Previously Announced Re-structuring Plan
January 27, 2025
·
6 min read
Business
Interpace Biosciences Announces Preliminary Full-year and Fourth Quarter 2023 Financial and Business Results
Interpace Biosciences, Inc. (“Interpace” or the “Company”) (OTCQX: IDXG) today announced financial results for the fourth quarter and full year ending December 31, 2023.
March 7, 2024
·
12 min read
Press Releases
Interpace Diagnostics® Announces Undefined Extension of Medicare Coverage for PancraGEN®, a Molecular Diagnostic Test That Assesses Cancer Risk of Pancreatic Cysts
July 29, 2024
·
6 min read
Press Releases
Interpace Biosciences Announces Record Third Quarter 2024 Financial and Business Results
November 4, 2024
·
10 min read
Business
Interpace Biosciences Announces Record Third Quarter 2023 Financial and Business Results
Interpace Biosciences, Inc. announced financial results for the third quarter ended September 30, 2023 and provided a business and financial update.
November 8, 2023
·
10 min read
1 of 10,824
Next
